Psychemedics Corporation (PMD)
NASDAQ: PMD · IEX Real-Time Price · USD
2.350
-0.020 (-0.84%)
At close: Jul 2, 2024, 4:00 PM
2.430
+0.080 (3.40%)
After-hours: Jul 2, 2024, 6:16 PM EDT
Psychemedics Market Cap
Psychemedics has a market cap or net worth of $13.64 million as of July 2, 2024. Its market cap has decreased by -48.71% in one year.
Market Cap
13.64M
Enterprise Value
14.18M
1-Year Change
-48.71%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since December 1, 1998, Psychemedics's market cap has decreased from $105.20M to $13.64M, a decrease of -87.03%. That is a compound annual growth rate of -7.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 13.60M | -20.93% |
Dec 29, 2023 | 17.20M | -37.91% |
Dec 30, 2022 | 27.70M | -28.79% |
Dec 31, 2021 | 38.90M | 38.43% |
Dec 31, 2020 | 28.10M | -44.36% |
Dec 31, 2019 | 50.50M | -42.22% |
Dec 31, 2018 | 87.40M | -22.59% |
Dec 29, 2017 | 112.90M | -16.25% |
Dec 30, 2016 | 134.80M | 145.09% |
Dec 31, 2015 | 55.00M | -32.43% |
Dec 31, 2014 | 81.40M | 4.23% |
Dec 31, 2013 | 78.10M | 37.74% |
Dec 31, 2012 | 56.70M | 19.12% |
Dec 30, 2011 | 47.60M | 11.48% |
Dec 31, 2010 | 42.70M | 11.78% |
Dec 31, 2009 | 38.20M | 13.35% |
Dec 31, 2008 | 33.70M | -59.83% |
Dec 31, 2007 | 83.90M | -15.76% |
Dec 29, 2006 | 99.60M | 39.69% |
Dec 30, 2005 | 71.30M | 7.38% |
Dec 31, 2004 | 66.40M | 37.19% |
Dec 31, 2003 | 48.40M | -1.43% |
Dec 31, 2002 | 49.10M | -43.37% |
Dec 31, 2001 | 86.70M | -20.46% |
Dec 29, 2000 | 109.00M | 1.02% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
China Jo-Jo Drugstores | 14.71M |
Star Equity Holdings | 14.39M |
Mustang Bio | 14.39M |
Novo Integrated Sciences | 14.29M |
Cara Therapeutics | 14.11M |
Immuron | 13.79M |
Edesa Biotech | 13.76M |
Aptose Biosciences | 13.75M |